Cargando…
Combined VEGF and CXCR4 antagonism targets the GBM stem cell population and synergistically improves survival in an intracranial mouse model of glioblastoma
Glioblastoma recurrence involves the persistence of a subpopulation of cells with enhanced tumor-initiating capacity (TIC) that reside within the perivascular space, or niche (PVN). Anti-angiogenic therapies may prevent the formation of new PVN but have not prevented recurrence in clinical trials, s...
Autores principales: | Barone, Amy, Sengupta, Rajarshi, Warrington, Nicole M., Smith, Erin, Wen, Patrick Y., Brekken, Rolf A., Romagnoli, Barbara, Douglas, Garry, Chevalier, Eric, Bauer, Michael P., Dembowsky, Klaus, Piwnica-Worms, David, Rubin, Joshua B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259439/ https://www.ncbi.nlm.nih.gov/pubmed/25238146 |
Ejemplares similares
-
Novel chemical library screen identifies naturally occurring plant products that specifically disrupt glioblastoma-endothelial cell interactions
por: Sengupta, Rajarshi, et al.
Publicado: (2015) -
The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor
por: Karpova, D, et al.
Publicado: (2013) -
CXCL12 Mediates Trophic Interactions between Endothelial and Tumor Cells in Glioblastoma
por: Rao, Shyam, et al.
Publicado: (2012) -
The RNA-binding protein AKAP8 suppresses tumor metastasis by antagonizing EMT-associated alternative splicing
por: Hu, Xiaohui, et al.
Publicado: (2020) -
VEGF and Pleiotrophin Modulate the Immune Profile of Breast Cancer
por: Lynn, Kristi D., et al.
Publicado: (2010)